Metabolomic signatures of lipid-modifying therapies using drug target Mendelian randomization

This study compares the detailed lipoprotein lipid effects of 8 lipid-lowering drug targets, as assessed with genetic and Nightingale's biomarker data in >100,000 individuals from UK Biobank.